Science Explorer Interactive view Map
Company · Berkeley Heights · United States

Chugai Pharma (United States)

In research, Chugai Pharma (United States) stands highest in Medicine (#9,080 of 10,443 worldwide) and Health Sciences (#10,902 of 11,982 worldwide), 2022–2025.

chugai-pharm.comROR OpenAlex
World rank, 2022–2025
#14,250
of 28,054 · #13,155 all time
Rank in United States
#1,989
of 4,192
Research works
1.4k
▼ 22% vs 2013–17
Citations
26k
18.7 per fractional work
Top-10% rate
11.1%
record average 16.5%
Open access
57%
world 28%

What is Chugai Pharma (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #9,080 of 10,443 12.6%64 #7237
Health SciencesDomain #10,902 of 11,982 12.0%68 #9488

Each strip is that field’s whole ranked pool, with the notch where Chugai Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.22× its world share, 22 worksBiochemistry, Geneti…Immunology and Microbiology: 5.01× its world share, 6 worksImmunology and Micro…Neuroscience: 0.47× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.33× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 4.86× its world share, 2 worksChemical EngineeringChemistry: 2.05× its world share, 4 worksChemistryComputer Science: 0.32× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 0.22× its world share, 0 worksEarth and Planetary …Engineering: 0.25× its world share, 5 worksEngineeringEnvironmental Science: 0.32× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.38× its world share, 2 worksMaterials ScienceMathematics: 2.06× its world share, 3 worksMathematicsPhysics and Astronomy: 0.13× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.33× its world share, 1 worksHealth ProfessionsMedicine: 2.63× its world share, 64 worksMedicineNursing: 1.60× its world share, 1 worksNursingVeterinary: 6.41× its world share, 1 worksVeterinaryDecision Sciences: 0.34× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.58× its world share, 2 worksEconomics, Econometr…Psychology: 0.40× its world share, 2 worksPsychologySocial Sciences: 0.18× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 6.4×. Every wedge is a field page.

Who are the top researchers at Chugai Pharma (United States)?

Ranked on the composite score, Masahiko Mihara, Yoshiyuki Ohsugi and Takehisa Kitazawa lead among researchers whose main affiliation is Chugai Pharma (United States).

  1. 1 Masahiko Mihara United States · #278,521 worldwide 117 citations · 18 works
  2. 2 Yoshiyuki Ohsugi United States · #341,675 worldwide 65 citations · 19 works
  3. 3 Takehisa Kitazawa United States · #343,873 worldwide 96 citations · 29 works
  4. 4 Tomoyuki Igawa United States · #450,548 worldwide 97 citations · 21 works
  5. 5 Noboru Kubodera United States · #460,848 worldwide 76 citations · 25 works
  6. 6 Yoshio Takagaki United States · #580,740 worldwide 60 citations · 15 works
  7. 7 Yoshihiro Nitta United States · #1,087,150 worldwide 43 citations · 43 works
  8. 8 Norio Shirakawa United States · #1,106,078 worldwide 7 citations · 16 works
  9. 9 Kazushige Sakai United States · #1,369,294 worldwide 39 citations · 26 works
  10. 10 Atsuhiko Kato United States · #1,380,079 worldwide 18 citations · 27 works
All ranked researchers at Chugai Pharma (United States)

Which keywords describe research at Chugai Pharma (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Fc Receptors, Inflammation, Biopharmaceuticals and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies14▲ 126×3 topics
  2. Therapeutic Antibodies13▲ 144×2 topics
  3. Glycosylation11▲ 75×3 topics
  4. Inflammation10▲ 3.6×24 topics
  5. Antibody Engineering9▲ 126×1 topic
  6. Fc Receptors9▲ 126×1 topic
  7. Biopharmaceuticals6▲ 96×3 topics
  8. Immunotherapy6▲ 6.8×13 topics
  9. Cancer6▲ 3.4×20 topics
  10. Immunogenicity6▲ 102×2 topics
  11. Drug Discovery5▲ 19×4 topics
  12. Chemotherapy5▲ 5.3×9 topics
  13. Recombinant Proteins5▲ 117×2 topics
  14. Targeted Therapy5▲ 16×4 topics
  15. Clinical Trials4▲ 5.2×6 topics
  16. Lymphoma4▲ 21×2 topics
  17. Tumor Microenvironment4▲ 7.6×7 topics
  18. Protein Aggregation4▲ 60×1 topic
  19. Stability4▲ 14×1 topic
  20. Cancer Therapy4▲ 5.0×8 topics
  21. Cancer Immunotherapy4▲ 18×2 topics
  22. Pharmacokinetics4▲ 11×6 topics
  23. Protein-Protein Interactions3▲ 57×2 topics
  24. Autoantibodies3▲ 10×7 topics
  25. Angiogenesis3▲ 7.2×7 topics
  26. PET Imaging3▲ 14×3 topics
  27. Foldamers3▲ 70×1 topic
  28. Peptide Synthesis3▲ 70×1 topic
  29. CAR T Cells3▲ 30×1 topic
  30. Chimeric Antigen Receptor3▲ 30×1 topic
  31. Rituximab3▲ 15×3 topics
  32. Tumor Regression3▲ 20×2 topics
  33. Molecular Docking3▲ 17×2 topics
  34. Monoclonal Antibody3▲ 41×2 topics
  35. Immune Checkpoint Blockade3▲ 18×1 topic
  36. PD-1 and PD-L13▲ 18×1 topic
  37. Gene Therapy2▲ 10×4 topics
  38. Genomic Profiling2▲ 19×2 topics
  39. Inhibitors2▲ 48×2 topics
  40. Prophylaxis2▲ 15×2 topics

Which research topics does Chugai Pharma (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Chemical Synthesis and Analysis and CAR-T cell therapy research.

Monoclonal and Polyclona…9Monoclonal and Polyclonal Antibodies Research: 9 fractional worksProtein purification and…4Protein purification and stability: 4 fractional worksChemical Synthesis and A…3Chemical Synthesis and Analysis: 3 fractional worksCAR-T cell therapy research: 3 fractional worksCancer Immunotherapy and Biomarkers: 3 fractional worksLung Cancer Treatments a…2Lung Cancer Treatments and Mutations: 2 fractional worksHemophilia Treatment and Research: 2 fractional worksComputational Drug Discovery Methods: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksStatistical Methods in Clinical Trials: 2 fractional works
Radiology, Nuclear Medicine and ImagingMolecular BiologyOncologyPulmonary and Respiratory Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 9 works
  2. 2 Protein purification and stability Molecular Biology 4 works
  3. 3 Chemical Synthesis and Analysis Molecular Biology 3 works
  4. 4 CAR-T cell therapy research Oncology 3 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  7. 7 Hemophilia Treatment and Research Hematology 2 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  9. 9 HER2/EGFR in Cancer Research Oncology 2 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.1%not open42.9%

World: 28% of research is openly available.

with international co-authors30.1%domestic only69.9%

World: 19% is written across borders.

How has Chugai Pharma (United States)'s research output changed?

Output in 2018–2022 was 22% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berkeley Heights

All research institutions in Berkeley Heights

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.